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Most mammalian tissue cells experience oxygen partial pressures in vivo equivalent to 1–6% O2 (i.e., physioxia). In standard cell
culture, however, headspace O2 levels are usually not actively regulated and under these conditions are ~18%. This drives
hyperoxia in cell culture media that can affect a wide variety of cellular activities and may compromise the ability of in vitro
models to reproduce in vivo biology. Here, we review and discuss some specific O2-consuming organelles and enzymes,
including mitochondria, NADPH oxidases, the transplasma membrane redox system, nitric oxide synthases, xanthine oxidase,
and monoamine oxidase with respect to their sensitivities to O2 levels. Many of these produce reactive oxygen and/or nitrogen
species (ROS/RNS) as either primary end products or byproducts and are acutely sensitive to O2 levels in the range from 1% to
18%. Interestingly, many of them are also transcriptional targets of hypoxia-inducible factors (HIFs) and chronic cell growth at
physioxia versus 18% O2 may alter their expression. Aquaporins, which facilitate hydrogen peroxide diffusion into and out of
cells, are also regulated by HIFs, indicating that O2 levels may affect intercellular communication via hydrogen peroxide. The O2
sensitivities of these important activities emphasize the importance of maintaining physioxia in culture.
1. Introduction
Mammalian cells are typically cultured under hyperoxic con-
ditions. While most cells experience oxygen levels of 1–6%
in vivo (physioxia; Table 1), almost all mammalian cell culture
is done in humidified atmospheric air at 37°Cwith CO2 added
to 5%. Although the headspace O2 level is usually not mea-
sured, it is 18-19% under these conditions due to displace-
ment of O2 by water vapour and CO2. When O2 levels used
in cell culture experiments are measured and reported, these
are virtually always those of headspace gas and not media.
Particularly in metabolically active cells growing in high den-
sity, the pericellular media O2 levels that cells experience may
be substantially lower than headspace O2 levels [1–3], since
O2 is continually removed from media by mitochondrial res-
piration and by other O2-consuming cellular activities.
O2 participates in many metabolic reactions, some of
which are sensitive to O2 levels in the range between phy-
sioxia and 18%. Therefore, mammalian cells should be cul-
tured in physiologically relevant O2 levels. Where this is not
done, it is important to be aware of the potential conse-
quences on cellular functions. One potential consequence of
elevated O2 in cell culture media is increased cellular produc-
tion of reactive oxygen (ROS) and nitrogen (RNS) species.
This probably contributes to the observed effects of high O2
levels on cell senescence, differentiation, and apoptosis,
amongst a wide range of other less well-characterized effects
([4–6]; Fehrer et al. 2007).
There is a growing appreciation of the role of O2 levels in
cell biology (e.g., [7, 8]). However, there is a limited mecha-
nistic understanding of how supraphysiological O2 levels
influence specific O2-dependent processes. In this review,
we consider the O2 sensitivity of some of the important O2-
consuming organelles and enzymes in mammalian cells in
the range between physioxia and 18% O2 (standard cell cul-
ture conditions). We use the Michaelis-Menten constant
(Km(O2)) for each O2-consuming enzyme (where this value
is available) as a convenient way to compare O2 sensitivity
across a broad range of different organelles and enzymes.
All O2 and Km(O2) values from published works have been
converted to % O2 at 37
°C, since % O2 is the unit of measure-
ment used in most descriptions of cell culture experiments.
In general, higher Km(O2) values are indicative of enzymes
that will be more sensitive to the differences between
in vivo and in vitro O2 levels. We address the physiological
role(s) of the metabolite(s) produced from these O2-consum-
ing reactions and the O2 sensitivity over the range from phys-
iological to 18% O2 of that reaction. We further summarize
the interesting observation that many of the O2-consuming
and ROS/RNS-producing enzymes are positively regulated
by hypoxia, in some instances specifically by hypoxia-
inducible factor-1 (HIF-1).
1.1. Oxygen Limitation of Mitochondrial Respiration in Cell
Culture. An important goal of maintaining higher O2 levels
in culture is to ensure that mitochondrial respiration is not
limited by O2 availability. Some of the most comprehensive
and physiologically relevant data on the O2 levels required
to sustain maximal mitochondrial respiration rates have been
provided by Hoffmann et al. (2009), who measured these
values for isolated liver mitochondria while systematically
varying O2 concentrations. State 4 respiration of complex I
or complex II substrates (glutamate/malate or succinate,
respectively) or of palmitoyl carnitine is near maximal at
~1% O2 (Hoffman 2009). Marcinek et al. (2003) showed that
respiration in skeletal muscle is not O2 limited until O2 falls
below ~0.5%, which is similar to the observation by Gnaiger
(2001) for isolated rat liver mitochondria. To understand
how this relates to O2 sufficiency in cell culture, we can com-
pare these values to the levels of O2 present in media imme-
diately outside of cells (pericellular O2) or within the cytosol
(Table 2).
Pericellular O2 values for adherent cell monolayers can
be measured in real time using a variety of approaches,
including Luxcel and Seahorse platforms (Agilent, USA). We
use PreSens OxyDish (PreSens Precision Sensing GMBH,
Germany) which has O2-sensitive fluorescent probes impreg-
nated into the tissue culture dish plastic. For most cell lines
seeded at typical densities and maintained in a 5% CO2 incu-
bator at 37°C without O2 control, headspace O2~18% and
pericellular O2 levels are close to this [3]. This is far in excess
of what is needed to support maximal mitochondrial respira-
tion rates. When headspace O2 is maintained at more physio-
logically relevant levels, however, pericellular and intracellular
O2 levels may become significantly lower, particularly if
media changes and/or mixing are infrequent.
Intracellular O2 levels can be measured in cultured cells
using a variety of fluorescent probes (Zhdanov et al. 2012;
[9]). Measurements using these tools show that, at the higher
levels of O2 (~20%) typical of standard cell culture, intracel-
lular O2 levels range from 14–17% depending upon cell type,
medium composition (specifically whether fuel source pro-
motes reliance on oxidative phosphorylation), and seeding
density (Table 2). Conditions promoting faster rates of O2
consumption lower these values, but they are generally
hyperoxic regardless. At more physiologically relevant head-
space O2 levels of 5–9%, intracellular O2 levels under typical
culture conditions range from 0.5% to 5%. Thus, under
standard cell culture conditions, intracellular O2 levels are
typically at least 10 times higher than what is required to sus-
tain maximal mitochondrial respiration rates based on the
Vmax values reported by Hoffman et al. (2009) and others.
On the other hand, cell culture at 5-6% headspace O2 results
in intracellular O2 levels that may be low enough to limit
respiration when cells are at high density or growing in
respiration-promoting media.
Although a higher than physiological headspace O2 level
in tissue culture helps to ensure that mitochondrial respira-
tion is not oxygen limited, it may have the unintended conse-
quence of stimulating the production of ROS and RNS from
various enzymes that are widely expressed in common cell
lines. Increases in ROS/RNS with concomitant effects on
Table 1: Average oxygen levels measured in human tissues and cells
in vivo.
Tissue/compartment pO2 (%) Reference
Brain 4.4± 0.3 [66]
Brain glioma cells (intracellular) 4.5± 0.5
Skin 1.1–4.6 [66, 67]
Liver 5.4± 0.7 [66, 68]
Liver (mitochondrial) 3-4 [69]
Skeletal muscle 3.8± 0.2 [70]
Skeletal muscle (intracellular) 3.4–4.8 Lanza et al. 2010
Kidney 9.5± 2.6 [66]
Kidney (intracellular) 6.6–7.9 [71]
Bone marrow 1.3–2 [72, 73]
Table 2: Intracellular O2 levels under various cell culture
conditions.
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redox-sensitive signaling events and potentially oxidative
macromolecular damage should be expected under these
conditions, and indeed, these are observed. It is therefore
important to understand the relationship between oxygen
levels and the rates of ROS/RNS production in cultured cells.
In mammalian cells, ROS/RNS are produced by a wide range
of organelles and enzymes, including mitochondria, NADPH
oxidase (Nox), nitric oxide synthase (NOS), monoamine oxi-
dase (MAO), xanthine oxidase/oxidoreductase (XO/XOR),
lipoxygenase (LOX), cyclooxygenase (COX), heme oxygen-
ase (HOX), and the transplasma membrane redox system
(tPMRS). Here, we discuss how the hyperoxia of standard
cell culture is expected to affect the activities and/or
expression of all these organelles and enzymes. Our list of
oxygen-dependent enzymes is not exhaustive, and we have
omitted some oxygen-metabolizing enzymes for which we
could not readily find data regarding oxygen sensitivity of
reaction rates.
1.2. Oxygen Concentration and Mitochondrial ROS
Production. Superoxide/H2O2 production as a byproduct of
oxidative phosphorylation has been well studied in isolated
mitochondria, and many sites of production, albeit under
generally nonphysiological conditions, have been identified
(Figure 1). The specific sites of mitochondrial superoxide
production have been reviewed recently (e.g., [10]) and will
not be detailed here. Superoxide produced at various sites
within mitochondria is released into either the matrix or
the IMS side of the inner membrane. H2O2 arising from
superoxide within the mitochondrial matrix can diffuse out
of the matrix.
Although mitochondria are often stated to be responsible
for the majority of cellular ROS production, this has not been
demonstrated [11] and indeed seems unlikely to be univer-
sally true given that the total cell volume occupied by mito-
chondria varies from a few percent in low-metabolic rate
cells to as much as 30% in cardiomyocytes [12]. Similarly,
the relative levels of other ROS and RNS producers like
Nox and NOS vary greatly between cell types and physiolog-
ical condition. Therefore, while it may be true that mitochon-
dria are the most important sites of ROS production in some
cell types, they may not be in others. Nonetheless, it is impor-
tant to consider the sensitivity of mitochondrial ROS produc-
tion to the oxygen levels prevailing in cells in culture.
Hoffman et al. (2007; 2009) provided detailed measure-
ments and calculations of H2O2 production (originating as
superoxide) from isolated liver mitochondria respiring in
state 4 on various substrates at 37°C (Table 3). Measurements
were made over a range of O2 levels, with and without vari-
ous respiratory poisons, allowing the calculation of Km(O2)
values for H2O2 production associated with different respira-
tory substrates and ETC sites. Notably, of the sites contribut-
ing to mitochondrial H2O2 production in cultured cells,
which is likely primarily the complex I FMN site and the
complex III Qo site, both are saturated at the same low
O2 levels as respiration. Note that ETFQOR is probably
not a major contributor to mitochondrial H2O2 production
under standard cell culture conditions because fatty acids
are not included as fuels in most commercial media. The
physiological relevance of complex I backflow is established
only in ischemia/reperfusion [13], and these would be
expected to occur in normal cell culture only as hypoxia-
hyperoxia transitions during media changes or passaging.
Therefore, based on the above observations, the rate of
mitochondrial ROS production is likely not O2-limited
under most standard cell culture conditions or at head-
space O2 levels as low as 5%, providing that intracellular
O2 remains above 0.5%. Thus, little difference is expected
in mitochondrial ROS production between 5% (physioxia)
and 18% (standard cell culture) O2.
1.3. NADPHOxidases. There are sevenmembers of the family
of nicotinamide adenine dinucleotide phosphate (NADPH)
oxidases (Nox1–5 and Duox 1 and 2), several of which (e.g.,
Nox1, 2, and 4) are quite widely distributed amongst mam-
malian tissues and cell lines [14]. Noxs are multisubunit
membrane-spanning enzymes that transport electrons from
NAD(P)H across biological membranes [15]. Although the
Nox enzymes localize to a variety of cellular membranes, all
can be found in the plasma membrane, where they transport
electrons to external O2, thus leading to the production of
superoxide in the extracellular space [14]. Superoxide pro-
duced outside the cell and dismuted to H2O2 can diffuse back
into the cell of origin or into neighbouring cells.
Importantly, recent work indicates that Nox4 differs
from other Nox isoforms in several important ways. Firstly,
Nox4 localizes (at least in some cells and/or some physiolog-
ical conditions) to mitochondria [16] where its activity
appears to interact with respiratory complex I and ATP [17,
18]. Nox4 activity is not dependent upon interactions with
accessory subunits. Furthermore, Nox4 preferentially pro-
duces H2O2 rather than superoxide [19]. The rate of Nox4
H2O2 production is also very sensitive to O2 levels in the
range between physioxia and 18%.
There is surprisingly little Km(O2) data for any of the Nox
isoforms. Furthermore, there is some doubt regarding the
validity of some assays of Nox activity using isolated mem-
brane fractions [20, 21]. Nonetheless, the available data sug-
gest that the activities of Nox1, Nox2, and Nox4 are all
sensitive to O2 levels in the range from 5% to 18% (Table 4).
Nox4, with a Km(O2) value~18%, is particularly sensitive
over this range; Nox4 activity triples between 3% and 12%
O2 [19]. Direct measurements with cultured PC3 and
C2C12 cells indicate a substantial contribution of Nox1
and/or Nox4 to H2O2 production in live cells (measured as
Amplex Red oxidation), particularly at 18% O2, since this
value is strongly inhibited by GKT138731 (a Nox1/4 inhibi-
tor; Figure 2). Similarly, in Nox1/2/4 triple knockout mouse
dermal fibroblasts, H2O2 production at 18% O2 is only about
1/10 to that in wild-type fibroblasts, and, at 5% O2, H2O2
production is undetectable (Figure 2). Thus, although some-
what limited, available evidence indicates that Nox isoforms
produce H2O2 at rates that are strongly dependent upon O2
levels. This probably underlies observations such as the
Nox4 contribution to cellular senescence in primary cell
lines, since these studies have been performed at 18% O2.
Whether Nox4 plays the same roles in vivo, where O2 levels
are several times lower, is not clear but must be considered.
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1.4. Transplasma Membrane Redox System. The transplasma
membrane electron transfer (tPMET) system is a ubiquitous
system for transferring electrons from cytosolic NAD(P)H
outside of the cell, similar to the Noxs [22]. The core compo-
nents of the tPMET system are the NAD(P)H-quinone
oxidoreductase (NQO1), NADH-cytochrome b5 reductase
(CytB5red), coenzyme Q10, and the ecto-NADH oxidase
disulfide thiol exchanger (ENox). Both NQO1 and CytB5red
are distributed in multiple intracellular localizations, includ-
ing in association with the plasma membrane.
The tPMET system makes significant contributions to
cellular O2 consumption in many common cell lines (e.g.,
Jurkat, RAW264.7, and pancreatic beta cells; see [23, 24]).
The tPMET system is highly upregulated in respiration-
deficient (ρ0) cells, which accumulate coenzyme Q10 in the
plasma membrane [25]. In ρ0 cells, the tPMRS may be the
predominant site of O2 consumption [24].
A variety of extracellular terminal electron acceptors
are possible, including O2, which can undergo single-
electron reduction to produce superoxide. Purified mamma-
lian CytB5red produces superoxide directly [26], though its
overexpression has beneficial effects in some specific con-
texts [27, 28]. NQO1 is associated with an intracellular anti-
oxidant function (e.g., [29]) but contributes to reduction of
extracellular electron acceptors, presumably including O2,
in pancreatic beta cells [23]. ENox proteins include several
isoforms—the age-related arNox may be the most relevant
in terms of ROS production in cell culture. This isoform
produces superoxide and becomes more highly expressed
in the tissues of aged mammals and in late-passage or
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Figure 1: Sites of H2O2 production in the mitochondrial electron transport chain. These include 2-oxoacid dehydrogenase, complex I (site
IF), complex I (site IQ), complex II (site IIF), complex III (site IIIQ0), the ETFQOR system (site EF), glycerol 3-phosphate dehydrogenase
(site Gq), and dihydroorotate dehydrogenase (site Dq). Complex I: O00217 (Homo sapiens); complex II: Q0QF01 (Sus scrofa); complex III:
P23004 (Bos taurus); complex IV: P68530 (Bos taurus); ATP synthase O00217 (Bos taurus); cytochrome c: P99999 (Homo sapiens);
glycerol 3-phosphate: P04406 (Homo sapiens); dihydroorotate dehydrogenase: ID3H (Homo sapiens); 2-oxoacid dehydrogenase: 2DNE
(Homo sapiens); ETFQOR: 2GMH (Sus scrofa). Data based on Wong et al. [10]. Structures retrieved from https://www.rcsb.org/.
Table 3: Km(O2) and Vmax values for H2O2 production from










Succinate (− rotenone) 0.179 330




Palmitoylcarnitine (− rotenone) 0.100 290
Palmitoylcarnitine (+ rotenone) 0.398 250
Sites
Complex III Qo site 0.199 150
Complex I FMN site 0.019 170
Complex I electron backflow 0.090 135
ETFQOR 0.498 200
All values are from Hoffman et al. 2009 and measured using an Amplex
Red/horseradish peroxidase assay in the presence of superoxide dismutase
at 37°C.
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The tPMET system has only been measured under stan-
dard cell culture O2 (18%), and we are not aware of any data
regarding the sensitivity of superoxide production to O2 con-
centration for the system as a whole or for individual compo-
nents of the system. Nonetheless, consideration should be
given to the possibility that the tPMRS is O2 sensitive in the
5–18% range and that O2-dependent changes in its activity
could affect cell physiology.
1.5. Role of Aquaporins in Transmembrane H2O2 and Gas
Diffusion. The tPMRS and all Nox isoforms (a portion of all
Nox isoforms localizes to the plasma membrane) can pro-
duce either superoxide or H2O2 on the extracellular side of
the plasmamembrane. Here, these ROSmay react withmem-
branes or membrane-bound proteins facing the extracellular
space on the originating cell or on neighbouring cells. Alter-
natively, H2O2, either directly produced or resulting from
superoxide dismutation, may cross cell membranes to exert
intracellular effects. The H2O2 permeability of phospholipid
bilayers is limited; indeed, H2O2 is less membrane permeant
than H2O [31]. However, H2O2 rapidly equilibrates across
cell membranes via aquaporins (AQPs). Structural studies
suggest that all water-transporting AQPs may facilitate
some degree of H2O2 movement across cellular membranes
[32]. However, empirical data is less equivocal, suggesting
that hAQP3 and hAQP8 are particularly good H2O2 trans-
porters [31].
Interestingly, O2 levels modulate the expression of several
AQPs. AQP1 and AQP3 mRNA and protein levels are both
increased at 1% versus 20% O2 ([33]; Hoogewijs et al.
2016), though AQP5 and AQP9 expressions are reduced at
lower O2 levels ([34]; Castro-Parodi et al. 2013). There is also
some evidence that hypoxia can affect AQP8 permeability
directly via posttranslational modifications [35]. Recent stud-
ies ([36]; Zwiazek et al. 2017) also suggest that some AQP
isoforms facilitate the transport of O2 and therefore may
facilitate O2 uptake by cells at low O2 levels. There is also
strong evidence that AQP1 and AQP4 can transport other
important ROS/RNS, such as NO [37, 38]. Taken together,
these observations indicate that media O2 levels are likely to
modulate the H2O2, NO, and O2 permeability of cell mem-
branes via their effects on AQP expression and/or activity.
This makes it more difficult to understand the detailed kinet-
ics of how ROS/RNS and gases traverse cellular membranes
Table 4: Km(O2) values for various O2-consuming enzymes.









Nox4 H2O2 18 [78]
Nox4 H2O2 18 [19]
Nox4 H2O2 16–20 [79]
nNOS NO 2.3 Purified bovine enzyme [45]
nNOS
NO/O2
− 2.2 Partially uncoupled rat enzyme
[42, 43]
O2
− 3.4 Fully uncoupled rat enzyme
nNOS NO 15.7 Purified rat enzyme [47]
nNOS NO 39.8 Purified rat enzyme [80]
nNOS NO 28.5 Kinetic model based on rat enzyme data [81, 82]
eNOS NO 0.8 Purified bovine enzyme [45]
eNOS NO 0.3 Kinetic model based on rat enzyme data [82, 83]
iNOS NO 0.63± 0.09 Purified bovine enzyme [45]
iNOS NO 11.0 Isolated enzyme assay [84]
iNOS NO 10.6 Kinetic model [82]
NOS NO 3.1–10.8 Unspecified isoform [48, 85]
XO O2
·−/H2O2 2.2–6.8 Isolated from bovine milk Fridovich et al. 1962, 1964
MAO H2O2 3.4–28 Mammalian enzymes; various substrates [86–88]; reviewed in [57]
HO CO, iron, and bilirubin <1.5 Unspecified isoform from chicken liver [59]
LOX H2O2 1–2.6 Unspecified isoform [65]
COX-1 Various 0.4–3.1 Arachidonic acid substrate [63, 89–91]
COX-2 Various 1.3–1.5 Arachidonic acid substrate [63, 65]
PHD Modified HIF 41–46 Various substrates [92]
FIH Modified HIF 4–12 Various substrates [92]
Nox: NADPH oxidase; NOS: nitric oxide synthase; XO: xanthine oxidase; MAO: monoamine oxidase; HO: heme oxygenase; LOX: lipoxygenase; COX:
cyclooxygenase; PHD: prolyl hydroxylase; FIH: factor inhibiting HIF-1.
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in vivo when measurements are done in vitro under nonphy-
siological O2 conditions.
1.6. Nitric Oxide Synthases. NOS are a family of enzymes
responsible for the production of NO and L-citrulline from
L-arginine and O2 [39, 40]. Three isoforms of NOS have been
identified: endothelial NOS (eNOS), neuronal NOS (nNOS),
and inducible NOS (iNOS) [41]. These three NOS isoforms
share approximately 50% amino acid identity [41], and all
three are widely expressed in mammalian tissues and cell
lines. Under some conditions, including transient anoxia/
reoxygenation, NOS catalyzes an “uncoupled” reaction
producing superoxide instead of NO (Stuehr et al. 1991;
[42, 43]; reviewed in [44]).
The first detailed study of the O2 sensitivity of the NOS
reaction was by Rengasamy and Johns [45] who calculated
a Km(O2) value of 0.63 to 2.31% O2 for NOS isolated from
bovine brain and aortic endothelium as well as RAW 264.7
mouse macrophages. Subsequently, Km(O2) values have been
published for various tissues and cell lines, as well as for spe-
cific purified NOS isoforms (Table 4). Although these values
vary widely, presumably due to differences in experimental
conditions, O2 affinities of nNOS and iNOS are found rela-
tively consistently to be within a range that is sensitive to
changes in O2 levels between physioxia and 18% O2. Cell
lines with high levels of these two isoforms will therefore pro-
duce more NO under standard cell culture conditions than
in vivo. Cell culture models of ischemia/reperfusion injury
typically employ a period of near anoxia followed by return
to “normoxia” where the latter is 18% O2. NOS activity can
be uncoupled under these conditions, and the rate of super-
oxide production upon reoxygenation at 18% O2 likely
exceeds that which would occur upon a return to physioxia
in vivo.
NO can also be produced by the reduction of nitrite cat-
alyzed by several enzymes including XO/XOR [46]. This
reaction is promoted at lower O2 levels and makes it difficult
to predict the effect of O2 levels on NO production rates.
Thus, the relationship between cellular NO synthesis rates
and O2 levels will depend on the relative abundance of differ-
ent NOS isoforms, which have different sensitivities to O2.
In addition to its effects on NO synthesis, O2 levels influ-
ence NO metabolism ([47, 48]; reviewed in [49]). NO is
metabolized in cells by poorly characterized pathways. How-
ever, it is known that the rate of NO metabolism by cells is
faster at higher O2 levels [50]. Thus, higher O2 levels will
affect the rate of NO production from nNOS and iNOS while
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Figure 2: Cells produce more H2O2 at 18% versus 5% O2, but this is prevented or ameliorated by selective NADPH oxidase 1/4 inhibitor
GKT137831. (a) C2C12 mouse myoblasts, (b) PC-3 human prostate cancer cells, and (c) wild-type and NOX1/2/4 triple knockout mouse
dermal fibroblast cell lines were grown at 18% O2 in a humidified 37
°C CO2 incubator, at 5%, and assayed at either 5% or 18% O2 as in
Maddalena et al. [3]. H2O2 efflux from cells was measured using Amplex Red reagent (10-acetyl-3,7-dihydroxyphenoxazine). Krebs-Ringer
buffer (KRB) was used for the assays which consisted of 135mM NaCl, 5mM KCl, 1mM MgSO4, 0.4mM K2HPO4, 20mM HEPES,
5.5mM glucose, and 10% fetal bovine serum. During the experiment, cells were incubated in KRB-contained 50mM Amplex Red reagent
and 0.1 units/mL horseradish peroxidase enzyme in the presence of 5μM GKT 137831 or vehicle control. Data were analysed using
two-tailed t-tests. Bars represent the mean± SEM from at least five independent experiments. ∗p < 0 05.
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Again, it is difficult to predict how this will affect steady-state
NO levels in all cells. In activated RAW 264.7 cells in culture,
the maximum rates of NO production were observed at 8%
O2 [50], though the relationship between O2 and NO levels
in other cell types is unknown. The O2-dependent rate of
NO metabolism will in turn affect its diffusional distance
and therefore alter the subset of proteins modified in the cell
of origin or neighbouring cells. NO participates in many
regulatory posttranslational modifications of key proteins,
including those driving epigenetic modifications. Given these
diverse influences of NO on cellular functions and the effects
of O2 levels on synthesis, diffusion distance, and metabolism
of NO, there is clear potential to generate nonphysiologically
relevant results at nonphysiological O2 levels.
1.7. Other Oxidases. XO and MAO are two widely expressed
cellular oxidases whose products include superoxide and
H2O2. XO and its precursor XOR are expressed in mamma-
lian cells, where they localize to the cytosol and the external
face of the plasma membrane [51]. Both XO and XOR can
catalyze the oxidation of purines, producing superoxide rad-
ical and H2O2 [52]. Under some conditions, XO may also
catalyze NO production from nitrites and nitrates, a reaction
that is favoured at lower O2 [46]. However, the levels of
these latter compounds are relatively low in culture media
and this activity may therefore be of minor importance in
mammalian cell culture. The Km(O2) value of bovine XO
has been reported in the range of 3–6% O2 (Table 4). Inter-
estingly, the relative production of superoxide versus H2O2
by XO is also sensitive to O2 levels within the range found
in cell culture (1–21%), such that at O2 levels below 5%
O2, H2O2 formation is promoted [53]. In addition, high
O2 levels promote posttranslational modifications of XOR
that decrease its specific activity [54, 55]. Thus, O2 levels
in culture could affect the relative rates of ROS production
by XO/XOR as well as the relative amounts of superoxide
versus H2O2 produced.
MAO occurs as two isoforms, MAO-A and MAO-B.
Both are widely distributed in mammalian tissues [56]. They
localize to the outer mitochondrial membrane where they
catalyze the degradation of biogenic and dietary monoamines
such as norepinephrine, dopamine, tyramine, serotonin,
phenylethylamine, and benzylamine in a reaction producing
H2O2. The reported Km(O2) values of both isoforms vary
widely (Table 4) due to a complicated reaction mechanism
in which O2 affinity is strongly affected by monoamine con-
centrations (reviewed in [57]). MAO enzyme activities are
nonetheless predicted to be sensitive to O2 over the range
of 5–18%. Because the H2O2 produced by MAOs is near
the mitochondrial compartment, aberrant mitochondrial
and cytosolic redox signaling and/or macromolecular dam-
age may be caused by MAO enzymes in the O2 conditions
typical of standard cell culture.
1.8. Oxygenases. Oxygenases catalyze the incorporation of
oxygen into an organic substrate. Heme oxygenase (HOX),
lipoxygenase (LOX), and cyclooxygenase (COX) are all
widely expressed in mammalian tissues and cell lines. HOX
is important in the process of heme degradation, while both
COX and LOX assist in the breakdown of arachidonic acid
via two separate pathways.
HOX is localized in the endoplasmic reticulum (reviewed
in [58]). There are two isoforms, HOX-1 and HOX-2, sharing
an amino acid sequence identity of >45%. While HOX-2 is
constitutively expressed, HOX-1 is induced by endogenous
and exogenous stressors such as heavy metals, pharmacolog-
ical agents, inflammatory mediators, UV light, and oxidative
stress. HOX enzymes oxidize heme to produce carbon mon-
oxide, Fe2+, and biliverdin. HOX purified from chicken liver
has maximal activity at O2 levels as low as 1.5% ([59];
Table 4), indicating that this enzyme is likely O2 saturated
even in cells cultured in physioxia.
COX is a dioxygenase that catalyzes the first step of ara-
chidonic acid or linoleic acid breakdown leading to the pro-
duction of prostanoid derivatives (reviewed in [60]). COX
enzymes modulate cell growth and signaling pathways and
are implicated in cancer progression [61]. There are two iso-
forms, COX-1 and COX-2, with an amino acid sequence
homology of ~60%. COX enzymes localize to the endoplas-
mic reticulum membrane and nuclear envelope. These
enzymes catalyze two-step reactions. In the first step, cyclo-
oxygenase activity using molecular oxygen produces the
hydroperoxide prostaglandin G2 intermediate. Peroxidase
activity is then observed resulting in the formation of prosta-
glandin H2. The Km(O2) value of COX-1-catalyzed arachi-
donic acid oxidation varies between 0.4% and 3.1% O2,
while the Km(O2) value of COX-2 is somewhat lower
(Table 4). Activities of COX-1 and COX-2 saturate at around
10–20% O2 [62, 63]. Thus, these enzymes are also O2 sensi-
tive in the range of interest, and as their products modulate
various cellular activities including cell growth and differen-
tiation [61], it is possible that their increased activities at
18% O2 affect studies of cell physiology in culture.
LOX catalyzes the deoxygenation of polyunsaturated
fatty acids, producing a variety of oxygen and lipid radicals
under some conditions (reviewed in [60]). There are six
isoforms of LOX that are widely distributed in mammalian
tissues and cells. LOX enzymes produce ROS and lipid
radical species that participate in intracellular signaling
pathways. O2 levels affect the lipoxygenase reaction in
complex ways [64, 65], but the measured Km(O2) values
are 1–2.6% O2 (Table 4), making reaction rates O2 sensi-
tive in the relevant range.
1.9. Transcriptional Regulation of ROS/RNS-Producing
Enzymes. In addition to acute effects on the activities of
enzyme-catalyzed reactions, O2 levels in cell culture may
affect the expression of various O2-consuming enzymes and
organelles. HIF-1 and HIF-2 are heterodimeric transcription
factors whose activities are regulated by O2 via the degrada-
tion of the α-subunits (HIF-1α, HIF-2α). This reaction is
catalyzed by prolyl hydroxylase (PHD), which uses O2 and
2-oxoglutarate to hydroxylate the HIF-α subunits leading to
their subsequent ubiquitination and degradation. A second
reaction, hydroxylation of an asparagine in HIF-1α catalyzed
by the factor inhibiting HIF-1 (FIH), inhibits HIF-1 tran-
scriptional activity. Together, O2 regulates the levels and
activity of HIF-1 and/or HIF-2. Both hydroxylation reactions
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are O2 sensitive within the physioxia to 18% O2 range.
Mammalian PHD isoforms have a Km(O2) value~25% O2
andFIHKm(O2) value~11%(Table 4). In addition,PHDactiv-
ities may be modulated by ROS/RNS produced by many of
the enzymes discussed above at higher rates under standard
culture conditions.
Hundreds of genes are transcriptionally regulated by
HIFs, and interestingly, most of the ROS/RNS-producing
enzymes discussed above are amongst them. In our experi-
ments, the relative levels of Nox1 and Nox4 are much higher
at 5% compared to 18% O2 (Figure 3). Indeed, Nox4, all three
NOS isoforms, LOX, COX, MAO, and HOX are all transcrip-
tional targets of HIFs (Table 5). In addition, several AQPs are
HIF regulated, indicating that the H2O2 permeability of cel-
lular membranes is likely different at physioxia versus 18%
O2. It is important to note that virtually, all data regarding
the HIF regulation of these enzymes has been collected using
18% O2 as “normoxia” and 1% O2 as hypoxia but similar
results are expected for 5% versus 18% comparison.
In terms of the impact on cell culture experiments, the
effects of O2 on the specific activities (based on Km(O2)
values) versus levels of O2-consuming proteins (based on
transcriptional upregulation) would tend to oppose each
other, though our measurement of higher rates of cellular
ROS production at 18% O2 versus 5% O2 suggests that they
do not cancel. It is unclear to what extent the combined
effects of media O2 on acute metabolic flux through the var-
ious O2-consuming pathways and the transcriptional regula-
tion via HIF-1/2 activation of their component proteins,
would impact cell physiology. Indeed, it seems impossible
to predict how the hyperoxia of cell culture will impact the
numerous O2-sensitive, O2-consuming, metabolic reactions
overall given these concomitant changes in specific activity
and expression.
1.10. Conclusions. Under standard cell culture conditions,
media O2 levels of typically~18% are hyperoxic with respect



















































Figure 3: Reduced levels of NADPH oxidases 1 and 4 at 18% versus 5% O2. (a) Representative Western blots showing Nox1 and β-tubulin in
PC-3 cells or Nox4 and β-tubulin in C2C12 cells, at 5% and 18% O2. (b, c) Average Nox1 signal (b) or Nox4 signal (c) standardized to
β-tubulin. Total cellular proteins were extracted by treating cells with NP-40 buffer (150mM NaCl, 1% NP-40, 50mM Tris-HCl
pH 8.0). Total protein (15 μg per sample) was resolved on 10% SDS-PAGE, transferred to a polyvinylidene difluoride membrane,
and probed for Nox1 or Nox4. β-Tubulin was used as an internal loading and transfer control. All antibodies were purchased from
Novus Biologicals; Nox1 (NBP1-31546), Nox4 (NB110-5885), β-tubulin (NB600-936). Data were analysed using two-tailed Student’s
t-tests. Bars represent means± SEM from at least five independent experiments. ∗p < 0 05. The identities of bands at intermediate
molecular weight are unknown.
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(Table 1). This disparity has important consequences for the
accurate modeling of in vivo cell physiology, so it is impor-
tant to have a comprehensive understanding of how O2
affects specific ROS/RNS-producing processes. Although
rates of ROS production from mitochondrial respiration are
relatively insensitive to increases in O2 levels from 5% to
18% O2, many widespread O2-consuming cellular enzymes
are very sensitive in this same range. In particular, the activ-
ities of Nox4, nNOS, eNOS, and both MAO isoforms appear
to be strongly induced at higher O2 levels. These enzymes
will thus produce substantially more ROS/RNS, potentially
affecting the states of intracellular signaling pathways and
the downstream events they are regulating. This is unlikely
to be an appropriate starting point upon which to impose
further stresses and expect a “normal” physiological response
that mimics an in vivo context.
In addition to acute effects of O2 on flux through specific
metabolic pathways, there is evidence that chronic exposure
to the hyperoxia of cell culture will also affect the expression
of Nox, NOS, MAO, and other O2-consuming enzymes
(Table 5). Presumably, this is a homeostatic mechanism for
tuning these reactions to O2 availability. However, it again
establishes a baseline condition that may not accurately
model the in vivo state. Even the permeability of cellular
membranes to H2O2, NO, or O2 may be influenced by O2-
mediated transcriptional regulation of AQPs, given their role
in facilitating the diffusion of these molecules (Table 5).
The specific effects of O2 on cellular ROS/RNS production
described above point to the importance of culturing cells at
physiologically relevant O2 levels. In most cases, this requires
lowering the incubator headspace O2 levels. However, this
can cause pericellular and intracellular hypoxia, depending
upon cell density and mitochondrial respiration rates.
Therefore, it is further necessary to monitor pericellular O2
levels and take steps to maintain them within a physiologi-
cally relevant range. We have found that standing O2 gradi-
ents from the top of the media column to the pericellular
region are present in undisturbed cell culture and that regu-
lar gentle mixing (e.g., via a rocker plate) can abolish these.
Our simple solution to this problem will be presented in a
future publication.
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